Zenith's tolazamide
Executive Summary
Shipments of the Tolinase generic began Oct. 3 following final FDA approval. Firm said its prices are 50% of Upjohn's direct price to drug stores as listed in the July Redbook. Upjohn figures were $53.51 for 250 mg 200s and $261.25 for 250 mg 1,000s. Zenith said initial shipments of its 100, 250 and 500 mg tolazamide are in excess of $1 mil. A generic version of Pfizer's Diabinese (chlorpropamide) will also be introduced after the patent expires Oct. 24
You may also be interested in...
Quick Listen: Scrip’s Five Must-Know Things
Join us for an audio catch-up on the latest major developments in the global biopharma industry, as reported by
Pink Sheet Podcast: Woodcock To Be Acting US FDA Chief, Key Staff Depart, Political Donations Shift
Pink Sheet reporters and editor discuss President-Elect Joe Biden’s decision to name the CDER director as acting FDA commissioner and other staffing changes, as well as changes to industry trade groups’ political donations.
Liquid Biopsy Company Delfi Diagnostics Raised $100M For New Class of Early Cancer Detection Test
Delfi Diagnostics will use the new funds to expand its team of cancer researchers and machine-learning experts to validate its novel approach for early cancer detection through multiple prospective clinical trials.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: